Open AccessSuccessful treatment of acute promyelocytic leukemia in a patient under hemodialysis with arsenic trioxide
Author(s) -
Hashimoto Akiko,
Tanaka Yasuhiro,
Ishikawa Takayuki,
Shinzato Isaku
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4417
Subject(s) - arsenic trioxide , acute promyelocytic leukemia , medicine , hemodialysis , kidney disease , adverse effect , arsenic , intensive care medicine , retinoic acid , biochemistry , materials science , chemistry , metallurgy , gene
A man with chronic kidney disease (CKD) under hemodialysis was diagnosed with acute promyelocytic leukemia (APL). He received arsenic trioxide as a single agent and achieved complete molecular remission without severe adverse events. Arsenic trioxide (ATO) can be used safely and effectively for APL with CKD.